Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
dc.authorid | 0000-0002-7584-3868 | |
dc.authorid | 0000-0001-8650-299X | |
dc.authorid | 0000-0003-4642-3693 | |
dc.authorid | 0000-0002-0853-4096 | |
dc.authorid | 0000-0002-3783-7432 | |
dc.authorid | 0000-0003-0558-9371 | |
dc.authorid | 0000-0001-8825-4918 | |
dc.authorwosid | Cicin, Irfan/AAQ-5575-2020 | |
dc.authorwosid | Demirkazık, Ahmet/AAG-7699-2020 | |
dc.authorwosid | Paydas, Semra/F-3132-2018 | |
dc.authorwosid | Yumuk, Perran Fulden/A-6189-2018 | |
dc.authorwosid | Şenler, Filiz Çay/AAI-1824-2019 | |
dc.authorwosid | , yesim/AAD-7194-2020 | |
dc.authorwosid | Yildiz, Ibrahim/AAF-9885-2019 | |
dc.contributor.author | Kilickap, S. | |
dc.contributor.author | Demirci, U. | |
dc.contributor.author | Buğdaycı, F. | |
dc.contributor.author | Tural, D. | |
dc.contributor.author | Korkmaz, T. | |
dc.contributor.author | Paydas, S. | |
dc.contributor.author | Cicin, İrfan | |
dc.contributor.author | Seber, Selçuk | |
dc.date.accessioned | 2022-05-11T14:40:56Z | |
dc.date.available | 2022-05-11T14:40:56Z | |
dc.date.issued | 2019 | |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı | |
dc.description.abstract | [No Abstract Available] | |
dc.identifier.doi | 10.1016/j.jtho.2019.08.1166 | |
dc.identifier.endpage | S559 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | S558 | |
dc.identifier.uri | https://doi.org/10.1016/j.jtho.2019.08.1166 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/8981 | |
dc.identifier.volume | 14 | |
dc.identifier.wos | WOS:000492162203082 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.institutionauthor | Seber, Selçuk | |
dc.language.iso | en | |
dc.publisher | Elsevier Science Inc | |
dc.relation.ispartof | Journal of Thoracic Oncology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | ALK positive | |
dc.subject | ROS1 positive | |
dc.subject | Lorlatinib | |
dc.subject | Advanced stage lung cancer | |
dc.title | Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey | |
dc.type | Conference Object |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 8981.pdf
- Boyut:
- 419.92 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text